ClinicalTrials.Veeva

Menu

Double Balloon Catheter Versus Dinoprostone Vaginal Insert for Cervical Ripening.

U

Università degli Studi dell'Insubria

Status and phase

Completed
Phase 4

Conditions

Cervical Ripening
Labor Induction

Treatments

Device: Double balloon catheter
Drug: Dinoprostone 10 mg controlled-release vaginal insert

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To compare the efficacy of transcervical double balloon catheters versus controlled release dinoprostone vaginal inserts for pre-induction cervical ripening in term women with unfavourable cervices.

Enrollment

210 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • singleton gestation
  • gestational age greater than 34 weeks
  • cephalic presentation
  • intact membranes
  • Bishop score of ≤4
  • reactive fetal heart rate (FHR) pattern on admission

Exclusion criteria

  • any condition precluding vaginal delivery
  • any contraindication to receiving prostaglandins, including history of asthma, glaucoma, or cardiac or cardiovascular disease
  • previous cesarean section or other uterine incision

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

210 participants in 2 patient groups

Dinoprostone Vaginal Insert
Active Comparator group
Treatment:
Drug: Dinoprostone 10 mg controlled-release vaginal insert
Double Balloon Catheter
Experimental group
Treatment:
Device: Double balloon catheter

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems